Hypothyroidism therapy: A critical revision;Tratamiento actual del hipotiroidismo: Una revisión crítica

Endocrinologia y Nutricion

Volumn 48, Issue 3, 2001, Pages 78-81

  Escobar Morreale, H F ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

DRUG DISPOSITION; HORMONE RELEASE; HUMAN; HYPOTHYROIDISM; MEDICAL DECISION MAKING; REVIEW; THYROTROPIN BLOOD LEVEL;

EID: 0035041581     PISSN: 15750922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1575-0922(01)73509-7     Document Type: Review

References (24)

1. K.A. Woeber Subclinical thyroid dysfunction Arch Intern Med 157 1997 1065 1068
2. C. Wang L.M. Crapo The epidemiology of thyroid disease and implications for screening Endocrinol Metab Clin North Am 26 1997 189 218
3. A. Pilo G. Iervasi F. Vitek M. Ferdeghini F. Cazzuola R. Bianchi Thyroid and peripheral production of 3,5,3’-triiodothyronine in humans by multicompartmental analysis Am J Physiol 1990 1990 E715 E726
4. M. Saberi R.D. Utiger Serum thyroid homrone and thyrotropin concentrations during thyroxine and triiodothyronine therapy J Clin Endocrinol Metab 39 1974 923 927
5. S. Taylor M. Kapur R. Adie Combined thyroxine and triiodothyronine for thyroid replacement therapy Br Med J 1 1970 270 271
6. R.N. Smith S.A. Taylor J.C. Massey Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism Br Med J 4 1970 145 148
7. M.I. Surks A.R. Schadlow J.H. Oppenheimer A new radioimmunoassay for plasma L-triiodothyronine: measurement in thyroid disease and in patients maintained on hormonal replacement J Clin Invest 51 1972 3104 3113
8. R. Bunevicius G. Kazanavicius R. Zalinkevicius A. Prange Jr Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism N Engl J Med 340 1999 424 429
9. H.F. Escobar-Morreale M.J. Obregón R. Calvo F. Escobar del Rey G. Morreale de Escobar Continuous infusion of different doses of T4 or T3 in thyroidectomized rats: circulating and tissue levels of T4 and T3 Program of the 67ht Annual Meeting of the American Thyroid Association, Tampa 1993 T49
10. H.F. Escobar-Morreale M.J. Obregón F. Escobar del Rey G. Morreale de Escobar Replacement therapy for hypothyroidism with thyroxine aloe does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats J Clin Invest 96 1995 2828 2838
11. H.F. Escobar-Morreale F. Escobar del Rey M.J. Obregón Escobar. Morreale de Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat Endocrinology 137 1996 2490 2502
12. L.H. Fish H.L. Schwartz J. Cavanaugh M.W. Steffes J.P. Bantle J.H. Oppenheimer Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in human N Engl J Med 316 1987 764 770
13. H.F. Escobar-Morreale M.J. Obregon F. Escobar del Rey G. Morreale de Escobar Tissue-specific patterns of changes in 3,5,3’-triiodo-L-thyronine concentrations in thyroidectomized rats infused with increasing dose of the hormone. Which are the regulatory mechanisms? Biochimie 81 1999 453 462
14. H.F. Escobar-Morreale M.J. Obregón A. Hernández F. Escobar del Rey G. Morreale de Escobar Regulation of iodothyronine deiodinase activity as studied in thyroidectomized rats infused with thyroxine of triiodothyronine Endocrinology 138 1997 2559 2568
15. S.M. Gow G. Caldwell A.D. Toft J. Seth A.J. Hussey V.M. Sweeting Relationship between pituitary and other target organ responsiveness in hypothyroid patients receiving thyroxine replacement J Clin Endocrinol Metab 64 1987 364 370
16. E. Brucket P. Giral R. Chadarevian G. Turpin Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients J Cardiovasc Risk 6 1999 327 331
17. W.M. Wiersinga Hypothyroidism L.J. DeGroot G. Hennemann Thyroid disease manager 2000 The University of Chicago Pritzker School of Medicine-Endocrine Education Chicago: URL: www.thyroidmanager.org
18. B. Biodi S. Fazio E.A. Palmieri C. Carella N. Panza A. Cittadini Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism J Clin Endocrinol Metab 84 1999 2064 2067
19. M. Bettendorf K.G. Schmidt J. Grulich-Henn H.E. Ulmer U.E. Heinrich Triodothyronine treatment in children after cardiac surgery: a doubleblind, randomised, placebo-controlled study Lancet 356 2000 529 534
20. D.S. Cooper R. Halpern L.C. Wood A.A. Levin E.C. Ridgway L-thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial Ann Intern Med 101 1984 18 24
21. R. Jaeschke G. Guyatt H. Gerstein C. Patterson W. Molloy D. Cook Does treatment with L-thyroxine influence health status in middleaged and older adults with subclinical hypothyroidism? J Gen Intern Med 11 1996 744 749
22. E. Nyström K. Caidahl G. Fager C. Wikkelso P.A. Lundberg G. Lidstedt A double-blind cross-over 12-month study of L-thyroxine treatment of women with ’subclinical’ hypothyroidism Clin Endocrinol (Oxf) 29 1988 63 75
23. R. Arem D. Escalante Subclinical hypothyroidism: epimiology, diagnosis, and significance Adv Intern Med 41 1996 213 250
24. A.E. Hak H.A. Pols T.J. Visser H.A. Drexhage A. Hofman J.C. Witteman Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study Ann Intern Med 132 2000 270 278